Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$1.79 - $4.65 $387,339 - $1.01 Million
-216,391 Closed
0 $0
Q4 2021

Feb 04, 2022

SELL
$4.11 - $15.13 $978,833 - $3.6 Million
-238,159 Reduced 52.39%
216,391 $998,000
Q3 2021

Nov 08, 2021

SELL
$10.32 - $16.9 $284,316 - $465,594
-27,550 Reduced 5.71%
454,550 $6.88 Million
Q2 2021

Aug 09, 2021

SELL
$14.98 - $23.89 $74,900 - $119,450
-5,000 Reduced 1.03%
482,100 $7.87 Million
Q1 2021

May 12, 2021

BUY
$17.95 - $25.91 $8.74 Million - $12.6 Million
487,100 New
487,100 $9.29 Million

About NexImmune, Inc.


  • Ticker NEXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,155,600
  • Market Cap $5.56M
  • Description
  • NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...
More about NEXI
Track This Portfolio

Track Times Square Capital Management, LLC Portfolio

Follow Times Square Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.